| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.41 | 0.008 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |